Literature DB >> 20058108

Chitosan-mediated siRNA delivery in vitro: effect of polymer molecular weight, concentration and salt forms.

Sunee Techaarpornkul1, Sirirat Wongkupasert, Praneet Opanasopit, Auayporn Apirakaramwong, Jurairat Nunthanid, Uracha Ruktanonchai.   

Abstract

The aim of this study was to investigate chitosan/siRNA complexes formulated with various chitosan salts (CS) including chitosan aspartate (CS-Asp), chitosan glutamate (CS-Glu), chitosan acetate (CS-Ac), and chitosan hydrochloride (CS-HCl) for in vitro siRNA delivery into stable and constitutive enhanced green fluorescent protein (EGFP)-expressing HeLa cells. The CS/siRNA complexes were characterized by 2% agarose gel electrophoresis and investigated for their transfection efficiency in stable and constitutive EGFP-expressing HeLa cells. The cytotoxicity of the complexes was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The formation of complexes CS/siRNA is mainly dependent on the weight ratio, whereas salt form and molecular weight has less effect. The particle sizes of the complete complexes were in the range of 270-373 nm except the complete complex of CS-Ac, with a slightly positive charge of less than 2 mV. The ability of CS to transfer functionally active siRNA into cell culture is mainly dependent on the weight ratio and molecular weight of CS whereas salt form of CS has less effect. The high gene-silencing efficiency was observed with low MW of CS (20 kDa) and high weight ratio of 32. Over 80% average cell viabilities were observed for CS/siRNA complexes in all weight ratios comparison to untreated cells. This study suggests CS salts have the potential to be used as safe siRNA delivery vectors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20058108      PMCID: PMC2850492          DOI: 10.1208/s12249-009-9355-6

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  20 in total

Review 1.  RNA interference--2001.

Authors:  P A Sharp
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

2.  Mechanism of cell transfection with plasmid/chitosan complexes.

Authors:  T Ishii; Y Okahata; T Sato
Journal:  Biochim Biophys Acta       Date:  2001-09-03

3.  The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.

Authors:  Xiudong Liu; Kenneth A Howard; Mingdong Dong; Morten Ø Andersen; Ulrik L Rahbek; Mads G Johnsen; Ole C Hansen; Flemming Besenbacher; Jørgen Kjems
Journal:  Biomaterials       Date:  2007-02       Impact factor: 12.479

4.  Delivery of siRNA from lyophilized polymeric surfaces.

Authors:  Morten Ø Andersen; Kenneth A Howard; Søren R Paludan; Flemming Besenbacher; Jørgen Kjems
Journal:  Biomaterials       Date:  2007-10-24       Impact factor: 12.479

5.  Water-soluble and low molecular weight chitosan-based plasmid DNA delivery.

Authors:  M Lee; J W Nah; Y Kwon; J J Koh; K S Ko; S W Kim
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

6.  Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems.

Authors:  N J Caplen; S Parrish; F Imani; A Fire; R A Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

7.  Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines.

Authors:  M Thanou; B I Florea; M Geldof; H E Junginger; G Borchard
Journal:  Biomaterials       Date:  2002-01       Impact factor: 12.479

8.  Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery.

Authors:  Theerasak Rojanarata; Praneet Opanasopit; Sunee Techaarpornkul; Tanasait Ngawhirunpat; Uracha Ruktanonchai
Journal:  Pharm Res       Date:  2008-06-18       Impact factor: 4.200

9.  Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA.

Authors:  So-Ly Wang; Hui-Hua Yao; Ling-Ling Guo; Liang Dong; Shi-Gang Li; Yong-Ping Gu; Zheng-Hong Qin
Journal:  Cancer Genet Cytogenet       Date:  2009-04-01

10.  Cationic nano-copolymers mediated IKKbeta targeting siRNA inhibit the proliferation of human Tenon's capsule fibroblasts in vitro.

Authors:  Yongheng Duan; Xipeng Guan; Jian Ge; Daping Quan; Yehong Zhuo; Hehua Ye; Tingting Shao
Journal:  Mol Vis       Date:  2008-12-31       Impact factor: 2.367

View more
  13 in total

1.  Chitosan-based hybrid nanocomplex for siRNA delivery and its application for cancer therapy.

Authors:  Min-Hyo Ki; Ji-Eon Kim; Young-Nam Lee; Sang Myoung Noh; Sung-Won An; Hyun-Jong Cho; Dae-Duk Kim
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

2.  Chitosan-Mediated shRNA Knockdown of Cytosolic Alanine Aminotransferase Improves Hepatic Carbohydrate Metabolism.

Authors:  Juan D González; Jonás I Silva-Marrero; Isidoro Metón; Albert Caballero-Solares; Ivan Viegas; Felipe Fernández; Montserrat Miñarro; Anna Fàbregas; Josep R Ticó; John G Jones; Isabel V Baanante
Journal:  Mar Biotechnol (NY)       Date:  2016-02       Impact factor: 3.619

3.  Counterion of Chitosan Influences Thermodynamics of Association of siRNA with a Chitosan-Based siRNA Carrier.

Authors:  Christelle Zandanel; Magali Noiray; Christine Vauthier
Journal:  Pharm Res       Date:  2020-01-02       Impact factor: 4.200

Review 4.  Micelle-like nanoparticles as carriers for DNA and siRNA.

Authors:  Gemma Navarro; Jiayi Pan; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2015-01-12       Impact factor: 4.939

5.  Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.

Authors:  Darryl T Martin; Jill M Steinbach; Jingchun Liu; Shogo Shimizu; Hristos Z Kaimakliotis; Marcia A Wheeler; Adam B Hittelman; W Mark Saltzman; Robert M Weiss
Journal:  Mol Cancer Ther       Date:  2013-11-12       Impact factor: 6.261

6.  Hydrodynamic delivery of chitosan-folate-DNA nanoparticles in rats with adjuvant-induced arthritis.

Authors:  Qin Shi; Huijie Wang; Covi Tran; Xingping Qiu; Françoise M Winnik; Xiaoling Zhang; Kerong Dai; Mohamed Benderdour; Julio C Fernandes
Journal:  J Biomed Biotechnol       Date:  2010-12-28

7.  Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide.

Authors:  Khaled Messaoudi; Patrick Saulnier; Kim Boesen; Jean-Pierre Benoit; Frederic Lagarce
Journal:  Int J Nanomedicine       Date:  2014-03-24

8.  Nanoparticle mediated P-glycoprotein silencing for improved drug delivery across the blood-brain barrier: a siRNA-chitosan approach.

Authors:  Jostein Malmo; Axel Sandvig; Kjell M Vårum; Sabina P Strand
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

9.  Chitosan combined with poly-L-arginine as efficient, safe, and serum-insensitive vehicle with RNase protection ability for siRNA delivery.

Authors:  Samarwadee Plianwong; Praneet Opanasopit; Tanasait Ngawhirunpat; Theerasak Rojanarata
Journal:  Biomed Res Int       Date:  2013-06-23       Impact factor: 3.411

10.  New aspects of gene-silencing for the treatment of cardiovascular diseases.

Authors:  Olivia Koenig; Tobias Walker; Nadja Perle; Almuth Zech; Bernd Neumann; Christian Schlensak; Hans-Peter Wendel; Andrea Nolte
Journal:  Pharmaceuticals (Basel)       Date:  2013-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.